NHS Rolls Out One-Minute Cancer Jab

The United Kingdom — National Health Service is rolling out a new one-minute injection of the immunotherapy drug Pembrolizumab (Keytruda), manufactured by Merck & Co., for tens of thousands of cancer patients across the UK. This innovative treatment, effective against various cancers including lung, breast, head and neck, and cervical, dramatically reduces administration time by up to 90% compared to traditional intravenous drips. Patients like Shirley Xerxes and Stephen Friend have already received the rapid jab at facilities such as Mount Vernon Cancer Centre, praising its convenience. This initiative is expected to free up significant staff time for the United Kingdom — National Health Service, improve patient experience, and help reduce waiting times for cancer treatment. Health officials and industry leaders, including Peter Johnson and Wes Streeting, have lauded the development for its potential to enhance productivity and capacity in cancer care.